Discover Suitable Embryos and Enhance Your Chance of Success with PGTseq-A

Discover Healthy Embryos and Enhance Your Chance of Success with PGTseq-A, an Advanced Embryo Chromosome Screening Technology

When planning your journey with IVF or ICSI, one important step is selecting embryos with the right chromosomal balance to support a healthy pregnancy. This is where PGT-A (Preimplantation Genetic Testing for Aneuploidy) can play a valuable role—helping to identify chromosomal abnormalities before embryo transfer.

Introducing PGTseq-A — an advanced platform developed in the USA that combines Targeted NGS with SNP analysis, offering more detailed information to support confident embryo selection.

3 Key Advantages of PGTseq-A

• Greater depth and coverage – Reads up to 10 million sequences, detecting abnormalities across all 23 chromosome pairs (2 sets), including small segmental anomalies down to ~3 Mb and rare conditions such as triploidy or haploidy.
• Enhanced insights – Goes beyond standard CNV methods by adding SNP analysis up to ~5,000 specific spots in the genome, offering clearer insights into embryos and supporting more informed embryo selection.
• Additional safeguards – Includes valuable checks such as Genetic PN Check (fertilization confirmation), DNA contamination detection, and Sibling Check to reduce risks of embryos being misidentified.

With this advanced approach, PGTseq-A provides doctors with deeper information to support clinical decision-making—helping families move forward with greater confidence.

Considering IVF or ICSI? Consult with our specialists, including the leading fertility specialist Dr. Wiwat Quangkananurug at SAFE Fertility Clinic, to learn how PGTseq-A may support your treatment plan.